Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

AGM Statement

23 Jul 2007 13:30

International Nuclear Solutions PLC23 July 2007 International Nuclear Solutions ("INS" or the "Company") Annual General Meeting At the Company's Annual General Meeting, held today, Chris Brown, Chairman ofINS, made the following comments: "The Board wish to make shareholders aware of the latest situation concerningthe offer from Babcock International Group PLC. As at 3.00 p.m. on 20th July 2007, Babcock International Group PLC ("Babcock")had acquired or had received acceptances in respect of a total of 34,334,293ordinary shares, representing 55.1 per cent. of the existing issued sharecapital of the Company. On Tuesday, 17th July 2007, Babcock wrote to the Board of the Company confirmingthat as the Company was not a wholly-owned subsidiary of Babcock, Babcock wouldbe unable to provide financial support to INS in the form of bonds andguarantees or any other form of financial instrument. In particular, Babcockwould not consider it appropriate to offer any form of guarantee to customers ofthe Company or any bank in respect of INS. However, if in the future INS was tobecome a wholly-owned subsidiary, Babcock would be in a position to offer suchfacilities. Whilst the Directors of INS do not consider that the absence of any financialsupport from Babcock will have a short term impact on the business, it willnevertheless limit the ability of INS to pursue some of the larger opportunitiesin the market place, as INS will only have access to these through thirdparties. Consolidation and re-structuring continues apace within the industry asdemonstrated by the recent sale of Nukem to a French conglomerate, theacquisition of BNFL's Magnox Reactor sites management company by US based EnergySolutions and the decision by the UK Government to sell the nucleardecommissioning division of UKAEA, which employs over 2,000 people. TheDirectors of INS believe that the UK nuclear industry is changing dramaticallyand that the larger nuclear focused companies and consortiums will become moredominant in the industry." All the resolutions proposed in the meeting as set out in the Company's annualreport were duly passed by a show of hands. 23 July 2007 Enquiries: International Nuclear Solutions plc 0161 222 5500Chris Brown, Non-executive ChairmanTony Moore, Chief Executive College Hill 020 7457 2020Matthew SmallwoodMatthew Gregorowski This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20237:00 amRNSTransfer of ToxHub Platform and launch of Centrus®
11th May 20233:26 pmRNSHolding(s) in Company
11th May 20237:00 amRNSUS Government Contract Award
4th May 20235:07 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSNotice of Results and Investor Presentation
2nd May 20234:13 pmRNSExercise of Options, Issue of Equity & TVR
14th Apr 20234:38 pmRNSHolding(s) in Company
13th Mar 20237:30 amRNSNo Exposure to Silicon Valley Bank
31st Jan 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
5th Jan 20237:00 amRNSExercise of Options, Director/PDMR Dealing & TVR
22nd Dec 20227:00 amRNSContract Extension with Leading CRO
30th Nov 20225:48 pmRNSHolding(s) in Company
12th Oct 20227:00 amRNSExercise of Options, Issue of Equity and TVR
27th Sep 20227:01 amRNSHalf-year Report
27th Sep 20227:00 amRNSSettlement of Historical Licence Dispute
13th Sep 20227:00 amRNSNotice of Results and Investor Presentation
9th Sep 20223:49 pmRNSHolding(s) in Company
2nd Sep 20227:00 amRNS$12m five-year agreement with Leading CRO
4th Aug 20227:00 amRNSHalf Year Trading Update
29th Jun 20225:03 pmRNSHolding(s) in Company
9th Jun 20224:01 pmRNSResult of AGM
20th May 20224:31 pmRNSHolding(s) in Company
17th May 20227:00 amRNSNotice of AGM & Posting of Annual Report
3rd May 202212:00 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSEuropean Medicines Agency Research Grant
26th Apr 20224:40 pmRNSSecond Price Monitoring Extn
26th Apr 20224:35 pmRNSPrice Monitoring Extension
26th Apr 202210:15 amRNSEarn Outs and Deferred Payments
26th Apr 20229:54 amRNSFinal Results
26th Apr 20227:00 amRNSAnnouncement re: full year results
20th Apr 20229:05 amRNSNotice of Results & Investor Presentation
15th Mar 20221:49 pmRNSGrant of PDMR Options
14th Mar 20225:29 pmRNSExercise of Options, Issue of Equity and TVR
14th Mar 202211:22 amRNSHolding(s) in Company
22nd Feb 202210:15 amRNSHolding(s) in Company
4th Feb 20228:08 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSAppointment of Joint Broker
21st Dec 20217:00 amRNSH2 China Market Update
13th Dec 20214:55 pmRNSHolding(s) in Company
22nd Nov 20212:33 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSNew In Silico Software Release
11th Oct 20213:15 pmRNSDirector/PDMR Shareholding
29th Sep 202110:34 amRNSHolding(s) in Company
29th Sep 20217:00 amRNSDirectorate Change
28th Sep 20217:00 amRNSGrant of PDMR Options
27th Sep 20217:00 amRNSHalf-year Report
14th Sep 20217:00 amRNSNotice of Results and Investor Presentation
14th Sep 20217:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.